Cargando…

Genetic stability of a recombinant adenovirus vaccine vector seed library expressing human papillomavirus type 16 E6 and E7 proteins

The aim of the present study was to understand the genetic stability of a master seed bank (MSB) and a working seed bank (WSB) of an adenovirus vector vaccine expressing the human papillomavirus (HPV) type 16 E6 and E7 fusion proteins (Ad-HPV16E6E7). Microscopic examination and viral infectious effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	WU, JIE, CHEN, KE-DA, GAO, MENG, CHEN, GANG, JIN, SU-FENG, ZHUANG, FANG-CHENG, WU, XIAO-HONG, JIANG, YUN-SHUI, LI, JIAN-BO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353792/ https://www.ncbi.nlm.nih.gov/pubmed/25780403 http://dx.doi.org/10.3892/etm.2015.2268

Ejemplares similares

Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein
por: Laurson, Joanna, et al.
Publicado: (2010)

Expression, purification and characterization of a recombinant fusion protein based on the human papillomavirus-16 E7 antigen
por: Granadillo, Milaid, et al.
Publicado: (2013)

Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions
por: Zhu, Jiang, et al.
Publicado: (2021)

Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7
por: Sato, Naoto, et al.
Publicado: (2018)

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
por: Peng, Shiwen, et al.
Publicado: (2021)

Serum Antibody against Unfused Recombinant E7 Protein of Human Papillomavirus Type 16 in Cervical Cancer Patients
por: Fujii, Takuma, et al.
Publicado: (1995)

Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells
por: Li, Li-xia, et al.
Publicado: (2013)

E6^E7, a Novel Splice Isoform Protein of Human Papillomavirus 16, Stabilizes Viral E6 and E7 Oncoproteins via HSP90 and GRP78
por: Ajiro, Masahiko, et al.
Publicado: (2015)

Human papillomavirus 16 (HPV 16) E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7
por: Hu, Yue, et al.
Publicado: (2020)

Immunogenicity of the recombinant adenovirus fusion-expressing E0-E2 gene of the classical swine fever virus
por: Zhang, Heng, et al.
Publicado: (2022)

Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription
por: James, Claire D., et al.
Publicado: (2020)

Genetic Variability in the E6/E7 Region of Human Papillomavirus 16 in Women from Ecuador
por: Zhingre, Alicia, et al.
Publicado: (2023)

Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
por: D'Costa, Zarina J., et al.
Publicado: (2012)

Stability of trivalent human papillomavirus (types 16, 18, 58) recombinant vaccine (Escherichia coli)
por: Liu, Yu-Ying, et al.
Publicado: (2021)

Human papillomavirus16 E6 but not E7 upregulates GLUT1 expression in lung cancer cells by upregulating thioredoxin expression
por: Gao, Zi-Yu, et al.
Publicado: (2021)

Localisation of Human Papillomavirus 16 E7 Oncoprotein Changes with Cell Confluence
por: Laurson, Joanna, et al.
Publicado: (2011)

An empty E1(−), E3(−), E4(−) adenovirus vector protects photoreceptors from light-induced degeneration
por: Takita, Hiroyasu, et al.
Publicado: (2008)

E6/E7 Variants of Human Papillomavirus 16 Associated with Cervical Carcinoma in Women in Southern Mexico
por: Antaño-Arias, Ramón, et al.
Publicado: (2021)

Genetic variation of E6 and E7 genes of human papillomavirus type 16 from central China
por: Li, Ting, et al.
Publicado: (2023)

Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation
por: Westrich, Joseph A., et al.
Publicado: (2018)

Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: “Adenovirus Vaccine Within an Adenovirus Vector”
por: Yan, Yuqian, et al.
Publicado: (2020)

Human papillomavirus 16 E7 oncoprotein alters the expression profiles of circular RNAs in Caski cells
por: Zheng, Si-Rong, et al.
Publicado: (2018)

Immunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18
por: Zhao, Li, et al.
Publicado: (2011)

REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
por: Zhou, Shu-Guang, et al.
Publicado: (2022)

Detection of Human Antibody against the Human Papillomavirus Type 16 E7 Protein
por: Hashido, Madoka, et al.
Publicado: (1991)

Characterization of a Species E Adenovirus Vector as a Zika virus vaccine
por: Bullard, Brianna L., et al.
Publicado: (2020)

Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer
por: Huang, Cheng‐Chih, et al.
Publicado: (2021)

Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
por: Paolini, Francesca, et al.
Publicado: (2021)

Human papillomavirus 16E6/E7 activates autophagy via Atg9B and LAMP1 in cervical cancer cells
por: Tingting, Chen, et al.
Publicado: (2019)

Human papillomavirus type 16 E6 induces cell competition
por: Brimer, Nicole, et al.
Publicado: (2022)

Human Papillomavirus 16 E2 Interaction with TopBP1 Is Required for E2 and Viral Genome Stability during the Viral Life Cycle
por: Prabhakar, Apurva T., et al.
Publicado: (2023)

Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation
por: Chalertpet, Kanwalat, et al.
Publicado: (2015)

Assessment of the Abundance and Potential Function of Human Papillomavirus Type 16 Circular E7 RNA
por: Wang, Richard C., et al.
Publicado: (2022)

Genetic variability in E6 and E7 oncogenes of human papillomavirus Type 16 from Congolese cervical cancer isolates
por: Boumba, Luc Magloire Anicet, et al.
Publicado: (2015)

Identification of Antibodies against Human Papillomavirus Type 16 E6 and E7 Proteins in Sera of Patients with Cervical Neoplasias
por: Sasagawa, Toshiyuki, et al.
Publicado: (1992)

Genetic diversity of E6, E7 and the long control region in human papillomavirus type 16 variants in Beijing, China
por: Wang, Jiao, et al.
Publicado: (2022)

Human papillomavirus E6 and E7: What remains?
por: Vats, Arushi, et al.
Publicado: (2021)

An oncolytic adenovirus 11p vector expressing adenovirus death protein in the E1 region showed significant apoptosis and tumour-killing ability in metastatic prostate cells
por: Wu, Haidong, et al.
Publicado: (2019)

Cytokine Responses to Adenovirus and Adenovirus Vectors
por: Atasheva, Svetlana, et al.
Publicado: (2022)

Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins
por: Di Bonito, Paola, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_givog6m8ik03l0o114nnrcek19